Resources
Blog
![](https://opyl.ai/wp-content/uploads/2023/06/Untitled-design-4-392x286.png)
07/06/23
Enhancing Access to Clinical Trials for Upper Gastrointestinal Cancer Patients
![](https://opyl.ai/wp-content/uploads/2023/06/Untitled-design-3-392x286.png)
01/06/23
Transforming Clinical Trial Consent: The Power of Digital Platforms
![person-interacting-with-a-phone](https://opyl.ai/wp-content/uploads/2023/05/person-interacting-with-a-phone-392x286.jpg)
22/05/23
Advancements in Clinical Trials: Embracing Digital Transformation
![](https://opyl.ai/wp-content/uploads/2023/05/woman-holding-a-sample-in-research-lab-392x286.jpg)
17/05/23
Embracing Change: The Future of Clinical Trials in Australia
![people sitting at a table for a discussion](https://opyl.ai/wp-content/uploads/2023/04/people-sitting-at-a-table-for-a-discussion-392x286.jpg)
17/04/23
Why You Should Promote Clinical Research Studies Like Brands?
![](https://opyl.ai/wp-content/uploads/2023/02/facebook-logo-image-392x286.jpg)
14/02/23
Depending on Meta for health research advertising? You could well be missing out
News
![](https://opyl.ai/wp-content/uploads/2022/10/Untitled-design-5-392x286.png)
05/09/23
Opin.AI Breaks Down Barriers in Clinical Trial Participation
![](https://opyl.ai/wp-content/uploads/2023/05/Prepped-and-primed-2023-Opyl-392x286.jpg)
17/01/23
2023 Prepped and Primed: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/12/2022-in-review-opyl-392x286.jpg)
07/12/22
Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher
![](https://opyl.ai/wp-content/uploads/2022/11/big_data_qantas_november_2022-392x286.jpg)
07/11/22
Big data could cure cancer
![](https://opyl.ai/wp-content/uploads/2023/05/Opyl-640x360-1-392x286.jpg)
21/10/22
Opyl’s TrialKey achieves major milestone with potential to improve clinical trial success rates
![](https://opyl.ai/wp-content/uploads/2022/10/1-darlinghurst-blog-post-image-20220923134602-392x286.webp)
30/09/22